Publication Name	World Journal of Gastroenterology
Manuscript ID	80412
Country	Germany

Received	2022-10-01 08:56
Peer-Review Started	2022-10-01 08:57
To Make the First Decision
Return for Revision	2022-11-05 04:44
Revised	2022-11-09 18:00
Second Decision	2022-12-20 08:13
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-12-21 03:45
Articles in Press	2022-12-21 03:45
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-12-30 05:59
Publish the Manuscript Online	2023-01-06 02:52

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier?
Manuscript Source	Invited Manuscript
All Author List	Christoph G Dietrich, Andreas Geier and Uta Merle
ORCID	Author(s) ORCID Number Christoph G Dietrich http://orcid.org/0000-0001-6927-7970 Andreas Geier http://orcid.org/0000-0002-9626-5083 Uta Merle http://orcid.org/0000-0003-1386-3350
Funding Agency and Grant Number
Corresponding Author	Christoph G Dietrich, MD, PhD, Consultant Physician-Scientist, Gastro-Praxis Wiesbaden, Leberzentrum Wiesbaden, Langenbeckplatz 2, Wiesbaden 65189, Germany. christoph.g.dietrich@gmail.com
Key Words	COVID-19; Postacute sequelae of COVID-19; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Inflammation; Fatty liver
Core Tip	The “colliding” pandemics of coronavirus disease 2019 (COVID-19) and non-alcoholic fatty liver disease (NAFLD) influence each other in several ways. Molecular similarities of cytokine pathways in both diseases including postacute sequelae of COVID-19 (PASC) may be responsible for amplification of chronic low-active inflammation. While there are conflicting data regarding the clinical influence of NAFLD on acute COVID-19 and vice versa, further research is necessary to study the long-term influence of COVID-19 hygienic measures and PASC on NAFLD.
Publish Date	2023-01-06 02:52
Citation	Dietrich CG, Geier A, Merle U. Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier? World J Gastroenterol 2023; 29(2): 367-377
URL	https://www.wjgnet.com/1007-9327/full/v29/i2/367.htm
DOI	https://dx.doi.org/10.3748/wjg.v29.i2.367

Full Article (PDF)	WJG-29-367.pdf
Full Article (Word)	WJG-29-367.docx
Manuscript File	80412_Auto_Edited-JLW.docx
Answering Reviewers	80412-Answering reviewers.pdf
Audio Core Tip	80412-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	80412-Conflict-of-interest statement.pdf
Copyright License Agreement	80412-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	80412-Language certificate.pdf
Peer-review Report	80412-Peer-review(s).pdf
Scientific Misconduct Check	80412-Bing-Wang JJ-2.png
Scientific Editor Work List	80412-Scientific editor work list.pdf